ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,00%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
80,995
0,24%
Bitcoin
68 596,31
1,24%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Meridian Bioscience Inc (VIVO)

  7. Meridian Bioscience Inc (VIVO) Actualités

VIVO

Meridian Bioscience (VIVO)

Meridian Bioscience Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VIVO
DateHeureSourceTitreSymboleSociété
13/02/202322h32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202317h41Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VIVOMeridian Bioscience Inc
09/02/202314h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VIVOMeridian Bioscience Inc
06/02/202312h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202320h34Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:VIVOMeridian Bioscience Inc
02/02/202320h13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202320h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VIVOMeridian Bioscience Inc
31/01/202319h56PR Newswire (US)SD Biosensor and SJL Partners Complete Transaction to Acquire Meridian BioscienceNASDAQ:VIVOMeridian Bioscience Inc
31/01/202315h41Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:VIVOMeridian Bioscience Inc
25/01/202323h58PR Newswire (US)DoubleVerify Holdings to Join S&P SmallCap 600NASDAQ:VIVOMeridian Bioscience Inc
10/01/202323h23Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VIVOMeridian Bioscience Inc
12/12/202214h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VIVOMeridian Bioscience Inc
12/12/202214h00PR Newswire (US)Meridian Bioscience Announces Anticipated Closing Date of the Pending MergerNASDAQ:VIVOMeridian Bioscience Inc
22/11/202214h29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VIVOMeridian Bioscience Inc
22/11/202214h00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS FOURTH QUARTER AND FULL YEAR FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
30/09/202223h29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VIVOMeridian Bioscience Inc
19/09/202218h24Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VIVOMeridian Bioscience Inc
25/08/202222h52Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:VIVOMeridian Bioscience Inc
08/08/202212h30TipRanksAnalysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Meridian Bioscience (VIVO) and Neurocrine (NBIX)NASDAQ:VIVOMeridian Bioscience Inc
05/08/202214h00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS THIRD QUARTER FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
29/07/202215h23PR Newswire (US)Meridian Bioscience Receives Re-Authorization from FDA for its Revogene® SARS-CoV-2 Molecular AssayNASDAQ:VIVOMeridian Bioscience Inc
07/07/202213h17PR Newswire (US)Meridian Bioscience, Inc. Enters into Agreement to Be Acquired by SD Biosensor and SJL Partners in $1.53 Billion All-Cash TransactionNASDAQ:VIVOMeridian Bioscience Inc
07/07/202213h12PR Newswire (US)Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third QuarterNASDAQ:VIVOMeridian Bioscience Inc
20/06/202214h38PR Newswire (US)Meridian Launches New qPCR Master Mixes for Stool Samples to Accelerate Development of Molecular AssaysNASDAQ:VIVOMeridian Bioscience Inc
27/05/202214h15Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:VIVOMeridian Bioscience Inc
26/05/202219h31PR Newswire (US)Meridian Bioscience responds to the Monkeypox Outbreak with its Inhibitor-Tolerant qPCR Master Mixes for the Development of Molecular TestsNASDAQ:VIVOMeridian Bioscience Inc
23/05/202219h13PR Newswire (US)Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment ConferenceNASDAQ:VIVOMeridian Bioscience Inc
17/05/202221h33PR Newswire (US)Meridian Bioscience Launches Lyo-Ready™ Saliva-Specific Isothermal Amplification Master Mixes for Direct Detection of DNA & RNA in Point of Care Diagnostic AssaysNASDAQ:VIVOMeridian Bioscience Inc
09/05/202212h15TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:VIVOMeridian Bioscience Inc
06/05/202214h00PR Newswire (US)MERIDIAN BIOSCIENCE REPORTS RECORD SECOND QUARTER FISCAL 2022 OPERATING RESULTSNASDAQ:VIVOMeridian Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:VIVO

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
NYSE
MRK
Merck
EU
EN
Bouygues
EU
ML
Michelin
EU
ORA
Orange
COIN
BTCUSD
Bitcoin
EU
LR
Legrand
EU
MC
Lvmh Moet Hennessy Louis...
EU
AI
Air Liquide
NASDAQ
MSFT
Microsoft
EU
RI
Pernod Ricard
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
EU
RNO
Renault
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés